Your session is about to expire
← Back to Search
Dietary Supplement
Hydrogen-rich Water for Mucositis
N/A
Recruiting
Led By Kartik Mani, MD
Research Sponsored by Clare Moran
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primary or recurrent tumor
Planning to receive daily fractionated radiotherapy for over 4 weeks' duration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
This trial investigates if drinking hydrogen-rich water can help head and neck cancer patients who have painful mouth sores from radiation therapy by reducing inflammation and pain.
Who is the study for?
This trial is for individuals with head and neck cancer, who are about to undergo daily radiotherapy for more than 4 weeks. Participants must be able to give consent, have a Karnofsky Performance Score of at least 70, swallow normally, and describe their pain.
What is being tested?
The study is testing if drinking hydrogen-rich water can reduce mouth sores caused by radiation therapy in head and neck cancer patients. It compares the effects of regular water (control) with water containing dissolved hydrogen tablets.
What are the potential side effects?
While not explicitly stated, potential side effects may include mild digestive discomfort or an unusual taste from the hydrogen tablets. Generally, hydrogen-rich water is considered safe with minimal risk of side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with head and neck cancer, at any stage.
Select...
I am scheduled for daily radiotherapy for more than 4 weeks.
Select...
I am able to care for myself but may not be able to do active work.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Group II: ControlPlacebo Group1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Oral Mucositis often involve the use of antioxidants, which work by reducing oxidative stress and inflammation—two major factors in the development of this condition. For instance, Hydrogen-Rich Water, which is being studied for its antioxidant properties, helps neutralize free radicals and decrease inflammatory responses.
This mechanism is crucial for Oral Mucositis patients as it can protect the mucosal lining of the mouth from damage, thereby alleviating pain, reducing the risk of secondary infections, and improving the overall quality of life during cancer treatments.
Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
Find a Location
Who is running the clinical trial?
Clare MoranLead Sponsor
Stony Brook UniversityLead Sponsor
223 Previous Clinical Trials
41,496 Total Patients Enrolled
DrinkHRWUNKNOWN
Kartik Mani, MDPrincipal InvestigatorStony Brook University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with head and neck cancer, at any stage.I can swallow food and water without any problems.I am scheduled for daily radiotherapy for more than 4 weeks.I am able to care for myself but may not be able to do active work.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Active
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.